Sun Yi, Lei Guo-Lin, Tang Cai, Yang Lu, Shen Hong, Wei Qiang
Department of Urology, West China Hospital of Sichuan University, No.37 Guoxue Xiang, Chengdu, 610041, Sichuan, China.
Department of Urology, People's Hospital of Jianyang City, Yiyuan Road, Jianyang, Sichuan, China.
Int Urol Nephrol. 2018 Sep;50(9):1597-1606. doi: 10.1007/s11255-018-1928-4. Epub 2018 Jul 14.
To compare the efficiency and complications of normal weight and overweight women with stress urinary incontinence (SUI) after surgery.
We searched the PubMed, Embase, and Cochrane Library Databases to identify all compared results, including those involving the terms normal weight, overweight, body mass index (BMI), and SUI. After treatment with surgery, the efficiency (subjective cure rate, objective cure rate, UDI-6, and IIQ-7) and complications were compared between the normal weight and overweight groups.
The study inclusion criteria were met by 20 studies involving 3829 patients. The data synthesized from these studies indicated that the subjective and objective cure rates in the normal weight group were significantly more effective than those in the overweight group (RR 1.07; 95% CI 1.04-1.10; P < 0.00001; RR 1.24; 95% CI 1.18-1.30; P < 0.00001), while the IIQ-7 and UDI-6 were no different between the two groups (MD 0.07; 95% CI - 1.44 to 1.58; P = 0.93; MD 0.18; 95% CI - 1.24 to 1.60; P = 0.81). For the data of complications, only the urgency was more in the overweight group (RR 0.68, 95% CI 0.55-0.84, P = 0.0003).
The objective success rate and subjective success rate of the surgery were higher in normal weight patients than those in overweight patients. Also, the side effects between the two groups were not significantly different.
比较体重正常和超重的压力性尿失禁（SUI）女性术后的疗效及并发症。
检索PubMed、Embase和Cochrane图书馆数据库，以确定所有比较结果，包括涉及体重正常、超重、体重指数（BMI）和SUI等术语的结果。手术治疗后，比较体重正常组和超重组的疗效（主观治愈率、客观治愈率、UDI - 6和IIQ - 7）及并发症。
20项研究纳入3829例患者，符合研究纳入标准。这些研究综合的数据表明，体重正常组的主观和客观治愈率显著高于超重组（RR 1.07；95% CI 1.04 - 1.10；P < 0.00001；RR 1.24；95% CI 1.18 - 1.30；P < 0.00001），而两组间IIQ - 7和UDI - 6无差异（MD 0.07；95% CI - 1.44至1.58；P = 0.93；MD 0.18；95% CI - 1.24至1.60；P = 0.81）。关于并发症数据，仅超重组尿急情况更多（RR 0.68，95% CI 0.55 - 0.84，P = 0.0003）。
体重正常患者手术的客观成功率和主观成功率高于超重患者。此外，两组间副作用无显著差异。
